These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11219329)

  • 41. Cognitive-behavioral therapy of insomnia: a clinical case series study of patients with co-morbid disorders and using hypnotic medications.
    Dolan DC; Taylor DJ; Bramoweth AD; Rosenthal LD
    Behav Res Ther; 2010 Apr; 48(4):321-7. PubMed ID: 20074701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia.
    Am Fam Physician; 1999 Jun; 59(11):3029-38. PubMed ID: 10392587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypnotic use for insomnia management in chronic obstructive pulmonary disease.
    Roth T
    Sleep Med; 2009 Jan; 10(1):19-25. PubMed ID: 18693067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
    Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical Problems before Initiating Pharmacotherapy for Insomnia].
    Semba J
    Seishin Shinkeigaku Zasshi; 2015; 117(4):277-82. PubMed ID: 26524839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of chronic insomnia in elderly persons.
    Bain KT
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quazepam in the short-term treatment of insomnia in outpatients.
    Aden GC; Thatcher C
    J Clin Psychiatry; 1983 Dec; 44(12):454-6. PubMed ID: 6361006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bright light treatment for night-time insomnia and daytime sleepiness in elderly people: comparison with a short-acting hypnotic.
    Usui A; Ishizuka Y; Matsushita Y; Fukuzawa H; Kanba S
    Psychiatry Clin Neurosci; 2000 Jun; 54(3):374-6. PubMed ID: 11186120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs for insomnia.
    Zisapel N
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
    Whitmore JN; Fischer JR; Storm WF
    Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia".
    Schwartz T; Nihalani N; Virk S; Jindal S; Costello A; Muldoon R; Azhar N; Hussein J; Tirmazi S
    Int J Psychiatr Nurs Res; 2004 Aug; 10(1):1146-50. PubMed ID: 15468607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of Zaleplon.
    Zammit GK; Kramer JA
    Prim Care Companion J Clin Psychiatry; 2001 Apr; 3(2):53-60. PubMed ID: 15014616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of insomnia and long-term use of sedative-hypnotic drugs in older patients.
    McMillan JM; Aitken E; Holroyd-Leduc JM
    CMAJ; 2013 Nov; 185(17):1499-505. PubMed ID: 24062170
    [No Abstract]   [Full Text] [Related]  

  • 56. Zaleplon overdose associated with sleepwalking and complex behavior.
    Liskow B; Pikalov A
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):927-8. PubMed ID: 15266187
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression.
    Goldschmied JR; Sengupta A; Sharma A; Taylor L; Morales KH; Thase ME; Thase ME; Weljie A; Kayser MS
    Psychopharmacol Bull; 2021 Jun; 51(3):50-64. PubMed ID: 34421144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleeping Pill Administration Time and Patient Subjective Satisfaction.
    Chung S; Youn S; Yi K; Park B; Lee S
    J Clin Sleep Med; 2016 Jan; 12(1):57-62. PubMed ID: 26285113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-related illusions and hallucinations with zaleplon.
    Stone JR; Zorick TS; Tsuang J
    Clin Toxicol (Phila); 2008 Apr; 46(4):344-5. PubMed ID: 17852167
    [No Abstract]   [Full Text] [Related]  

  • 60. Sedative-hypnotics and human performance.
    Johnson LC; Chernik DA
    Psychopharmacology (Berl); 1982; 76(2):101-13. PubMed ID: 6805019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.